Ability to Pay and the Decision to Medicate

Medical Care

Volumn 36, Issue 2, 1998, Pages 202-211

  Stuart, Bruce ^a   Grana, James ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b US Quality Algorithms Inc   (United States)

Author keywords

Cost sharing; Drug use; Elderly; Health insurance; Over the counter drugs; Prescription drugs

Indexed keywords

NON PRESCRIPTION DRUG;

AGED; ARTICLE; COMPARATIVE STUDY; COST; DRUG THERAPY; ECONOMICS; FEMALE; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; HEALTH STATUS; HUMAN; INCOME; INSURANCE; MALE; MEDICAID; MEDICARE; PRESCRIPTION; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

AGED; COST SHARING; DRUG THERAPY; DRUGS, NON-PRESCRIPTION; FEMALE; HEALTH SERVICES RESEARCH; HEALTH STATUS; HUMANS; INCOME; INSURANCE COVERAGE; INSURANCE, MEDIGAP; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICAID; MEDICARE PART B; PENNSYLVANIA; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 0031990720     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199802000-00009     Document Type: Article

References (20)

1. Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for drugs under Medicaid: Effects on therapy, cost, and equity. N Engl J Med 1987;317:550.
2. Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072.
3. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994;331:650.
4. Brian E, Gibbens S. California's MediCal co-payment experiment. Med Care 1974;12:54.
5. Nelson A, Reeder C, Dickson W. The effect of a Medicaid drug co-payment on the utilization and costs of prescription services. Med Care 1984;22:724.
6. Reeder C, Nelson A. The differential impact of co-payment on drug use in a Medicaid population. Inquiry 1985;4:396.
7. Harris BL, Stergachis A, Ried LD. The effect of drug co-payments on utilization and cost of pharmaceuticals in health maintenance organizations. Med Care 1990;28:907.
8. Smith DG. The effects of co-payments and generic substitution on the use and costs of prescription drugs. Inquiry 1993;30:189.
9. Birch S. Relationship between increasing prescription charges and consumption in groups not exempt from charges. J R Coll Gen Pract 1986;36:154.
10. Lavers R. Prescription charges, the demand for prescriptions, and morbidity. Applied Economics 1989;21:1043.
11. O'Brian B. The effect of patent charges on the utilization of prescription medicines. J Health Econ 1989;8:109.
12. Cameron A, Travedi P, Milne F, et al. A microeconomic model of the demand for medical care and health insurance in Australia. Rev Econ Studies 1988;55:85.
13. Leibowitz A, Manning W, Newhouse J. The demand for prescription drugs as a function of cost sharing. Soc Sci Med 1985;21:1063.
14. Smith DG, Kirking D. Impact of consumer fees on drug utilization. PharmacoEconomics 1992;2:335.
15. Stuart B, Grana J. Are prescribed and OTC medicines economic substitutes? A study of the effects of health insurance on medicine choices by the elderly. Med Care 1995;33:487.
16. Aday LA, Anderson RM. Equity of access to medical care: A conceptual and empirical overview. Med Care 1981;19:4.
17. Dillman D. Mail and Telephone surveys: The total design method. New York, NY: John Wiley, 1978.
18. Grotzinger KM, Stuart BC, Ahern F. Assessment and control of nonresponse bias in a survey of medicine use by the elderly. Med Care 1994;32:989.
19. Pennsylvania Department of Aging. Biannual report to the Pennsylvania General Assembly on the PACE program, July 1, 1990-December 31, 1990. Harrisburg, PA: Department of Aging, 1991.
20. Hausman J. Specification tests in econometrics. Econometrica 1978;24:413.